apt for her2 breast cancer patients with small tumours
Published 5 years ago • 253 plays • Length 8:16Download video MP4
Download video MP3
Similar videos
-
5:46
adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for her2-positive breast cancer
-
6:47
extended adjuvant therapy for her2-positive early breast cancer
-
3:56
san antonio breast cancer symposium 2008: poor prognosis on small, her2 positive tumours
-
4:35
a multi-histology basket trial of ado-trastuzumab emtansine in patients with her2 amplified cancers
-
1:28
dual her2 blockade in patients with her2-positive breast cancer after pcr
-
7:40
adjuvant trastuzumab did not improve outcomes for patients with her2-low breast cancer
-
6:17
sara tolaney, sabcs 2022: adjuvant paclitaxel and trastuzumab for node-negative her2 breast cancer
-
2:51
preventing brain metastases in patients with her2 or triple negative breast cancer
-
1:56
apt: adjuvant paclitaxel and trastuzumab for node-negative, her2 breast cancer
-
5:00
adjuvant endocrine therapy used to treat er her2- breast cancer
-
11:04
shorther trastuzumab treatment of her2 breast cancer: 9 weeks v 1 year
-
49:25
optimizing therapy in her2 disease with dr. hope s. rugo
-
3:50
update from kaitlin for high-risk her2-positive early breast cancer
-
4:25
managing her2-positive breast cancer
-
7:44
treatment options for her2 breast cancer: a comprehensive guide
-
3:49
her2dx: a new diagnostic tool for early-stage her2 positive breast cancer
-
12:47
trastuzumab deruxtecan vs trastuzumab emtansine in patients with her2 metastatic breast cancer
-
5:42
updates on managing her2-positive early breast cancer
-
9:00
immunotherapy shows early promise for patients with trastuzumab-resistant breast cancer